Skip to main content
Clinical Trials/JPRN-UMIN000039520
JPRN-UMIN000039520
Completed
未知

Determinants of Left Ventricular Reverse Remodeling following Percutaneous Coronary Intervention in Patients with Systolic Dysfunction - Determinants of LVRR following PCI in Patients with Systolic Dysfunction

The University of Tokyo0 sites286 target enrollmentFebruary 18, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Coronary artery disease
Sponsor
The University of Tokyo
Enrollment
286
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 18, 2020
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients without follow\-up left ventriculography 2\) Patients diagnosed as acute myocardial infarction 3\) Patients diagnosed as stress cardiomyopathy 4\) Patients who received coronary artery bypass grafting during the follow\-up period 5\) Patients who received cardiac resynchronization therapy during the follow\-up period

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Prediction of left ventricular reverse remodeling by optimal medical therapy using T1 mapping in patients with non-ischemic cardiomyopathyonischemic dilated cardiomyopathy
JPRN-UMIN000033121Kanagawa Cardiovascular and Respiratory Center100
Active, not recruiting
Not Applicable
Mechanisms of LV Remodeling in Hypertensive Patients Working on a Rotational Expeditionary Basis in the ArcticHeart Failure With Preserved Ejection Fraction
NCT05839028Tomsk National Research Medical Center of the Russian Academy of Sciences550
Active, not recruiting
Phase 1
Right ventriculAr reverse reModeling and hemodynamic improvement after add-on combination therapy (ambriSentan/PDE-5i) in PAH patientS (RAMSES)patients with pulmonary arterial hypertentionMedDRA version: 21.1Level: PTClassification code 10037400Term: Pulmonary hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2016-004806-32-ITITALIAN PULMONARY HYPERTENSION NETWORK, IPHNET54
Completed
Phase 2
A Study of Percutaneous Left Ventricular Reshaping of Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve LV Function Using the Accucinch System.functional mitral regurgitationheart failure10046973
NL-OMON39112Guided Delivery Systems, Inc.10
Not yet recruiting
Not Applicable
Improvement in Right Heart Chambers Dimensions After Closure of The Hole in the Heart Chamber Partition WallHealth Condition 1: Q211- Atrial septal defect
CTRI/2024/04/065177AIIMS Delhi Research Section